Checkpoint Therapeutics Inc (CKPT)
1.85
-0.14
(-7.04%)
USD |
NASDAQ |
May 22, 16:00
1.85
0.00 (0.00%)
After-Hours: 20:00
Checkpoint Therapeutics Cash from Financing (Quarterly): 12.79M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.79M |
| December 31, 2023 | 9.989M |
| September 30, 2023 | 9.101M |
| June 30, 2023 | 14.55M |
| March 31, 2023 | 6.809M |
| December 31, 2022 | 6.89M |
| September 30, 2022 | 1.008M |
| June 30, 2022 | 0.642M |
| March 31, 2022 | 6.347M |
| December 31, 2021 | 4.01M |
| September 30, 2021 | 1.542M |
| June 30, 2021 | 10.80M |
| March 31, 2021 | 23.92M |
| December 31, 2020 | 3.677M |
| September 30, 2020 | 25.02M |
| June 30, 2020 | 2.604M |
| March 31, 2020 | -0.056M |
| Date | Value |
|---|---|
| December 31, 2019 | 17.75M |
| September 30, 2019 | 3.341M |
| June 30, 2019 | 4.013M |
| March 31, 2019 | 0.355M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 7.758M |
| June 30, 2018 | -0.028M |
| March 31, 2018 | 20.84M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -2.222M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.056M
Minimum
Mar 2020
25.02M
Maximum
Sep 2020
8.237M
Average
6.578M
Median
Cash from Financing (Quarterly) Benchmarks
| QuidelOrtho Corp | -18.50M |
| Fortress Biotech Inc | 27.86M |
| Anavex Life Sciences Corp | 7.277M |
| Ocugen Inc | -0.145M |
| NovaBay Pharmaceuticals Inc | -0.597M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.474M |
| Free Cash Flow | -40.03M |
| Free Cash Flow Per Share (Quarterly) | -0.1966 |
| Free Cash Flow Yield | -90.11% |